Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer.
Mol Med
; 28(1): 67, 2022 06 17.
Article
in En
| MEDLINE
| ID: mdl-35715741
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Antineoplastic Agents, Hormonal
/
DNA Methylation
/
Membrane Proteins
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
Language:
En
Year:
2022
Type:
Article